Have your say in peri-/menopause research. Banner

Category: hysterectomy

Have your say in peri-/menopause research.

VITAL is the Virtual regIstry of peri-/menopause in AusTrALia. The VITAL program aims to improve health outcomes across Australia, co-creating real-world impact via knowledge development, research,… Continue Reading →

Read more

Menopause – resources and support

Perimenopause and menopause symptom checklist What is perimenopause and menopause? Perimenopause and Menopause Symptom Checker What other support is available?  

Read more

Menopause Alliance Australia

It’s time to create positive change! Women now spend over one-third of their life postmenopausal.      

Read more

Women could lead longer, healthier lives if we can #EmbraceEquity.

Power, privilege and priorities: Embrace equity in women’s healthcare. Under-researched and under-diagnosed Disbelief in women’s symptoms Gaps in medical research Consequences of gender bias… Continue Reading →

Read more

World Menopause Day – BMS & ITN Business Showcase

Celebrate World Menopause Day To celebrate World Menopause Day, the British Menopause Society has again partnered with ITN Business to bring an exclusive video… Continue Reading →

Read more

What is healthy aging and how do I find a Doctor?

Doctors who are members of the Australasian Menopause Society (AMS) have a special interest in women’s health in midlife and menopause, and the promotion… Continue Reading →

Read more

Did you know there is an initial screening tool to assist in the assessment of Hypoactive Sexual Desire Dysfunction (HSDD)?

Low Sexual Desire is Common Sexual difficulties and concerns are common across a woman’s lifespan, increasing at midlife and beyond menopause. The DSDS (Decreased… Continue Reading →

Read more

The Menopause Charity launches in the UK

Menopause specialist Dr Louise Newson has launched a new Crowdfunding campaign for The Menopause Charity, which she hopes will change millions of women’s lives… Continue Reading →

Read more

TGA accepts AndroFeme 1 for evaluation in postmenopausal women with Hypoactive Sexual Desire Dysfunction.

TGA accepts AndroFeme 1 for evaluation in postmenopausal women with HSDD. Perth, Western Australia; Dec. 05, 2019  — Lawley Pharmaceuticals today announced AndroFeme 1,… Continue Reading →

Read more

Global Consensus Position Statement on the Use of Testosterone Therapy for Women

The Global Consensus Position Statement on the Use of Testosterone Therapy for Women was simultaneously published on the 2nd September 2019 in Maturitas, Journal… Continue Reading →

Read more